GENETRONICS BIOMEDICAL CORPORATION, MAY 22, 2002

Company

INOVIO PHARMACEUTICALS, INC.

Filed

June 4, 2002

Accession Number

0000919574-02-001093

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →